Accéder au contenu
Merck

Evaluation of the amino acid binding site of Mycobacterium tuberculosis glutamine synthetase for drug discovery.

Bioorganic & medicinal chemistry (2008-05-09)
Anneli Nordqvist, Mikael T Nilsson, Svenja Röttger, Luke R Odell, Wojciech W Krajewski, C Evalena Andersson, Mats Larhed, Sherry L Mowbray, Anders Karlén
RÉSUMÉ

A combination of a literature survey, structure-based virtual screening and synthesis of a small library was performed to identify hits to the potential antimycobacterial drug target, glutamine synthetase. The best inhibitor identified from the literature survey was (2S,5R)-2,6-diamino-5-hydroxyhexanoic acid (4, IC(50) of 610+/-15microM). In the virtual screening 46,400 compounds were docked and subjected to a pharmacophore search. Of these compounds, 29 were purchased and tested in a biological assay, allowing three novel inhibitors containing an aromatic scaffold to be identified. Based on one of the hits from the virtual screening a small library of 15 analogues was synthesized producing four compounds that inhibited glutamine synthetase.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
L-Methionine sulfone
Sigma-Aldrich
L-Homoserine
Sigma-Aldrich
DL-5-Hydroxylysine hydrochloride
Sigma-Aldrich
L-Homocysteic acid, ≥95%
Sigma-Aldrich
L-(+)-2-Amino-4-phosphonobutyric acid, optical purity optical purity: ≥95% (HPLC, Marfey′s reagent)